Kangmei Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 5,412.007 million compared to CNY 11,445.545 million a year ago. Operating loss was CNY 27,141.841 million compared to CNY 3,869.060 million a year ago. Net loss was CNY 27,735.943 million compared to CNY 4,660.675 million a year ago. Basic loss per share from continuing operations was CNY 5.6158 compared to CNY 0.9896 a year ago.